Studies Presented At Diabetes Technology Meeting Demonstrate The Accuracy Of ARKRAY USA Blood Glucose Meters And Test Strips

MINNEAPOLIS, Oct. 23, 2015 /PRNewswire/ -- ARKRAY USA, Inc., a leader in diabetes care products, announced that two studies presented yesterday at the Diabetes Technology Meeting in Bethesda, Maryland  demonstrated the accuracy of ARKRAY's GLUCOCARD^® Shine meter and the GLUCOCARD Vital meter in measuring blood glucose levels. The ability to accurately measure glucose levels in blood is essential for people afflicted with diabetes so they can effectively manage the disease, according to the American Diabetes Association (ADA).

"The results of these studies show ARKRAY products meet new ISO accuracy performance requirements for blood glucose meters," said ARKRAY USA President Jonathan Chapman. "These studies demonstrate our commitment to provide affordable, accurate blood glucose meters and test strips that help those afflicted with diabetes to live a more fulfilling and healthier life."

Diabetes, or diabetes mellitus, is a metabolic type of disease in which affected people have high blood glucose (blood sugar), either because insulin production is inadequate (Type 2), or because the islet cells in the pancreas no longer produce insulin (Type 1, sometimes referred to juvenile diabetes). People with untreated diabetes typically experience frequent urination, become increasingly thirsty and hungry. The ADA estimates that more than 30 million Americans suffer from either Type 1 or Type 2 diabetes and that 25.9% of American's 65 years of age or greater will have diabetes.

About ARKRAY USA, Inc.

ARKRAY USA, Inc. is a division of ARKRAY, a global leader in diabetes care with headquarters in Kyoto, Japan. For more than half a century, ARKRAY has pioneered products to ensure that people who have diabetes - and the health professionals who care for them - can better manage the condition.  ARKRAY currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the U.S. The Company has a long history of developing cutting edge technology such as the first portable glucose analyzer available in the United States; the first HbA1C analyzer; and the first hand-held blood glucose meter. For more information, visit www.arkrayusa.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/studies-presented-at-diabetes-technology-meeting-demonstrate-the-accuracy-of-arkray-blood-glucose-meters-and-test-strips-300165538.html

SOURCE ARKRAY USA, Inc.